HONG KONG FDA Approval ANDA 214020

ANDA 214020

HONG KONG

FDA Drug Application

Application #214020

Application Sponsors

ANDA 214020HONG KONG

Marketing Status

Prescription001

Application Products

001POWDER;INTRAVENOUS50MG/VIAL0TIGECYCLINETIGECYCLINE

FDA Submissions

UNKNOWN; ORIG1AP2021-05-13STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

HONG KONG
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214020
            [companyName] => HONG KONG
            [docInserts] => ["",""]
            [products] => [{"drugName":"TIGECYCLINE","activeIngredients":"TIGECYCLINE","strength":"50MG\/VIAL","dosageForm":"POWDER;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/13\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-05-13
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.